Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Post by mineoneon Oct 06, 2008 9:15pm
425 Views
Post# 15509332

Spot

Spot

October 3, 2008–The spot uranium price continued to slip this week and TradeTech’s Uranium Spot Price Indicator fell to $51.00 per pound U3O8, down $1.00 from the September 30 Exchange Value. Transactions totaling less than 500 thousand pounds U3O8 equivalent are reported. Sellers continue to seek buyers and remain willing to discount prices in order to conclude transactions. Potential purchasers are being extremely cautious about expressing buying interest so as to avoid creating upward price pressure. However, the current price level is attracting significant interest from utilities and other discretionary buyers who sense that a market bottom may be at hand. Sellers are finding that they need not cut prices as sharply as in previous weeks in order to move material, and the gap between willing sellers and willing buyers appears to have narrowed considerably

. read more

September 30, 2008–The uranium spot market experienced a series of shocks over the course of September. The first tremor came when the credit crisis spilled over into the uranium market at mid-month when Lehman Brothers, which had been involved as a uranium market participant over the past two years, was forced into bankruptcy. Then as the credit crisis grew so too did supply, as both traditional and non-traditional sellers came to the market in an effort to raise cash. As a result of this increase in supply, TradeTech’s Exchange Value dropped by nearly 20 percent or $12.50, to $52.00 per pound U3O8.

In times of falling prices and uncertainty in the marketplace, many sellers prefer to sell material through off-market transactions, and the current environment is no exception. Sellers are hoping that a less noticeable entry into the market will allow them to place their material before the marketplace has an opportunity to react to this new supply with lower prices. Buyers, anticipating further price declines, are increasingly hesitant to commit to purchases and are backing away from the market. As a result, have-to sellers become more aggressive, essentially “leap-frogging” over one another in an effort to conclude transactions. This behavior will continue until suppliers have satisfied their need for cash and/or demand increases to absorb the excess supply.

Bullboard Posts